Company profile

Neuracle Science company profile

Newracle Science specializes in antibody treatment for neurodegenerative diseases.

Headquarters

Country code
KR
Continent
Asia

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$5.6M
Last funding
Series Unknown / $5.6M / 2024-05-21
Last equity funding
Series Unknown / $5.6M
Investors
2
Lead investors
1
Articles
3

Founders and investors

Lead investors

Quad Asset Management

Investors

Quad Asset ManagementTIPS Program